STAT1 and systemic sclerosis: Among the eight TFs selected as described above, STAT1 and STAT2 have been previously demonstrated to be constitutively upregulated in monocytes from Systemic Sclerosis patients and to correlate with the expression of STAT-target genes (Van Der Kroef et al., 2019).